查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511799

骨关节炎注射市场规模、份额、趋势分析报告：按註射剂类型、解剖结构、最终用途和细分市场预测，2024-2030 年

Osteoarthritis Injectables Market Size, Share & Trends Analysis Report By Injection Type (Hyaluronic Acid Injections, Corticosteroids Injections), By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

骨关节炎注射剂市场的成长与趋势：

根据Grand View Research, Inc.最新报告显示，预计2030年全球骨关节炎注射市场规模将达114.2亿美元，2024-2030年复合年增长率为6.82%。该市场的成长受到几个关键因素的影响。正如 2021 年 1 月关节炎健康资料所强调的那样，由于荷尔蒙变化和肌肉骨骼 (OA) 差异，50 岁至 60 岁的女性比男性更容易患手部和膝盖骨关节炎。此外，根据美国卫生研究院的数据，女性肥胖率较高，进一步增加了患病风险。光是在美国，预计到 2040 年骨关节炎患者人数将达到 7,000 万人。

老年人口的增加是市场扩张的主要因素。 NCBI 2023 年 5 月发布的报告预测，由于老化和肥胖的共同作用，到 2030 年，患有骨关节炎的人数将增加一倍以上，达到 6,700 万人。根据 2024 年 3 月 CDC 支持的 OAAA 研究，大多数病例预计发生在 65 岁及以上的人群中，目前 45% 的骨关节炎患者属于这个年龄层。这种人口结构的改变会影响生产力、降低工作效率并增加疾病负担。

研究和开发活动也推动了骨关节炎注射市场的成长，製药公司和研究机构专注于开发新药。 Biocenic 于 2024 年 1 月宣布对其膝关节 OA 创新治疗方法 JTA-004 进行 3 期研究，这表明了该行业对扩大治疗选择的承诺。学术研究机构也积极致力于开发新的治疗方法。例如，2023 年 3 月报告的临床实验药物 GP130 在治疗发炎和疼痛方面显示出希望。此外，Kolon TissueGene, Inc. 的 TG-C 治疗髋关节 OA 的 2 期临床试验旨在评估疼痛和生活品质的改善。

采用口服药物、手术和家庭疗法（例如佩戴杜松子酒浸泡的葡萄干和铜手镯来治疗骨关节炎）预计将对市场成长产生负面影响。由于以患者为中心且易于使用，止痛药、非类固醇抗发炎药和皮质类固醇等口服和局部药物的采用正在增加。此外，越来越多的研究活动开发新型口服药物来控制骨关节炎引起的发炎和疼痛，预计将在未来几年阻碍骨关节炎注射药物的市场扩张。例如，2022 年 2 月，Medivir AB 宣布对 MIV-711 的随机 2a 期临床试验及其对 OA 疼痛管理的症状和结构益处进行事后分析。 MIV-711 是一种口服药物，针对骨吸收和软骨降解。

骨关节炎注射市场报告亮点：

  • 由于 OA 处方率较高，透明质酸 (HA) 注射剂在 2023 年占据市场主导地位。
  • 2023年，膝骨关节炎领域将主导市场。膝骨关节炎在老年人中尤其常见，是美国50 岁以上男性骨关节炎的第二大原因。
  • 医院药房细分市场将在 2023 年占据市场主导地位医院药房在骨关节炎的治疗中发挥着至关重要的作用。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章全球骨关节炎注射市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 全球骨关节炎注射剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章 全球骨关节炎注射药物市场：注射药物种类预估及趋势分析

  • 2023年及2030年註射型市场占有率
  • 细分仪表板
  • 按註射类型分類的全球骨关节炎注射剂市场前景
  • 2018-2030年市场规模、预测及趋势分析

第五章全球骨关节炎注射市场：解剖估计与趋势分析

  • 2023 年和 2030 年解剖学市场占有率
  • 细分仪表板
  • 从解剖学角度看全球骨关节炎注射市场
  • 2018-2030年市场规模、预测及趋势分析

第六章全球骨关节炎注射市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 以最终用途分類的全球骨关节炎注射市场前景
  • 2018-2030年市场规模、预测及趋势分析

第七章全球骨关节炎注射市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Anika Therapeutics, Inc.
    • Bioventus.
    • Ferring Pharmaceuticals Inc.
    • Sanofi SA
    • Flexion Therapeutics, Inc.
    • Zimmer Biomet
    • Arthrex, Inc.
    • Royal Biologics
    • Teva Pharmaceutical Industries Ltd.

第9章结论与分析师的观点

Product Code: GVR-4-68040-291-5

Osteoarthritis Injectables Market Growth & Trends:

The global osteoarthritis injectables market size is anticipated to reach USD 11.42 billion by 2030, exhibiting a CAGR of 6.82% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing growth, influenced by several key factors. Women aged 50 to 60 are more susceptible to developing hand and knee osteoarthritis (OA) compared to men, due to hormonal changes and musculoskeletal differences, as highlighted by Arthritis-health data from January 2021. Additionally, obesity rates, higher among women according to the National Institutes of Health, further increase the risk. In the U.S. alone, it is projected that the number of osteoarthritis patients will reach 70 million by 2040.

The growing geriatric population is a significant driver for market expansion. An NCBI report from May 2023 predicts that the combination of an aging population and obesity will more than double the number of osteoarthritis patients to 67 million by 2030. The majority of cases are expected to occur in individuals aged 65 and above, with 45% of current osteoarthritis patients falling into this age group, according to an OAAA study supported by the CDC in March 2024. This demographic shift impacts productivity, reducing work efficiency and increasing the disease burden.

Research and development activities are also boosting the osteoarthritis injectables market growth, with pharmaceutical companies and research institutes focusing on the development of novel drugs for OA management. BioSenic's announcement in January 2024 regarding the phase 3 study of JTA-004, an innovative treatment for knee OA, demonstrates the industry's commitment to advancing treatment options. Academic and research institutes are also actively involved in developing novel therapies. For instance, a GP130 investigational drug, reported in March 2023, shows promise in managing inflammation and pain. Additionally, Kolon TissueGene, Inc.'s Phase 2 clinical trial for TG-C in hip OA aims to evaluate pain and quality-of-life improvements.

The adoption of oral drugs, surgery, and home remedies such as gin-soaked raisins or wearing copper bracelets for the treatment of OA is expected to adversely affect market growth. The adoption of oral and topical treatment drugs such as analgesics, NSAIDs, and corticosteroids, is increasing due to the patient-centric approach and ease of use. Moreover, increase in research activities to develop novel oral drugs to manage inflammation and pain due to OA is anticipated to hinder the market expansion of OA injectable drugs in the coming years. For instance, in February 2022, Medivir AB published the post-hoc analysis of a randomized phase 2a clinical trial of MIV-711 and its symptomatic and structural benefits for pain management of OA. MIV-711 is an orally administered drug targeting both bone resorption and cartilage degradation.

Osteoarthritis Injectables Market Report Highlights:

  • Hyaluronic Acid (HA) injections segment dominated the market in 2023, owing to its high prescription rate in OA.
  • Knee osteoarthritis segment dominated the market in 2023. Knee OA is a prevalent condition particularly affecting older individuals, with the U.S. witnessing it as the second leading cause of incapacity among men aged 50 years and above.
  • Hospital pharmacies segment dominated the market in 2023. Hospital pharmacies play a pivotal role in osteoarthritis management, owing to factors such as higher number of treatments performed in the hospital setting.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Injection Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Injection Type
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Osteoarthritis Injectables Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of osteoarthritis
      • 3.2.1.2. Growing geriatric population susceptible to osteoarthritis
      • 3.2.1.3. Increase in R&D activities for injectable drug development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Adoption of other treatment options
      • 3.2.2.2. High cost of treatment
  • 3.3. Global Osteoarthritis Injectables Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Pricing Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Global Osteoarthritis Injectables Market: Injection Type Estimates & Trend Analysis

  • 4.1. Injection Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Osteoarthritis Injectables Market by Injection Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Hyaluronic Acid Injections
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Corticosteroid Injections
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Platelet-rich Plasma (PRP) Injections
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Placental Tissue Matrix (PTM) Injections
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Acetylsalicylic Acid (ASA) Injections
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Osteoarthritis Injectables Market: Anatomy Estimates & Trend Analysis

  • 5.1. Anatomy Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Osteoarthritis Injectables Market by Anatomy Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Knee Osteoarthritis
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Hip Osteoarthritis
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Hand Osteoarthritis
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Osteoarthritis Injectables Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Osteoarthritis Injectables Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospital Pharmacies
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Retail Pharmacies
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Osteoarthritis Injectables Market: Regional Estimates & Trend Analysis by

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Anika Therapeutics, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Injection Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bioventus.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Injection Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Ferring Pharmaceuticals Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Injection Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sanofi S.A.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Injection Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Flexion Therapeutics, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Injection Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Zimmer Biomet
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Injection Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Arthrex, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Injection Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Royal Biologics
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Injection Type benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Teva Pharmaceutical Industries Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Injection Type benchmarking
      • 8.3.12.4. Strategic initiatives

Chapter 9. Conclusion and Analyst Perspective

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 5 North America Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 6 North America Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 9 U.S. Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 12 Canada Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Europe Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 15 Europe Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 16 Europe Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Germany Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 18 Germany Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 19 Germany Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 UK Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 21 UK Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 22 UK Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 France Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 24 France Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 25 France Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Italy Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 27 Italy Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 28 Italy Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Spain Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 30 Spain Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 31 Sapin Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Denmark Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 33 Denmark Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 34 Denmark Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Sweden Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 36 Sweden Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 37 Sweden Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Norway Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 39 Norway Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 40 Norway Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Japan Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 46 Japan Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 47 Japan Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 China Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 49 China Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 50 China Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 India Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 52 India Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 53 India Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Australia Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 55 Australia Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 56 Australia Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 South Korea Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Thailand Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 59 Thailand Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 60 Thailand Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Latin America Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
  • Table 62 Latin America Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 63 Latin America Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 64 Latin America Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Brazil Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 66 Brazil Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 67 Brazil Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 68 Mexico Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 69 Mexico Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 70 Mexico Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 72 Argentina Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 73 Argentina Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 MEA Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
  • Table 75 MEA Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 76 MEA Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 77 MEA Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 79 South Africa Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 80 South Africa Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 UAE Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 85 UAE Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 86 UAE Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global Osteoarthritis Injectables market: market outlook
  • Fig. 9 Global Osteoarthritis Injectables competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Global Osteoarthritis Injectables market driver impact
  • Fig. 15 Global Osteoarthritis Injectables market restraint impact
  • Fig. 16 Global Osteoarthritis Injectables market strategic initiatives analysis
  • Fig. 17 Global Osteoarthritis Injectables market: Injection Type movement analysis
  • Fig. 18 Global Osteoarthritis Injectables market: Injection Type outlook and key takeaways
  • Fig. 19 Hyaluronic Acid Injections market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Corticosteroid Injections market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Platelet-rich Plasma (PRP) Injections market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Placental Tissue Matrix (PTM) Injections market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Acetylsalicylic Acid (ASA) Injections market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Global Osteoarthritis Injectables market: Anatomy movement analysis
  • Fig. 26 Global Osteoarthritis Injectables market: Anatomy outlook and key takeaways
  • Fig. 27 Knee Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Hip Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Hand Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global Osteoarthritis Injectables market: End-use movement analysis
  • Fig. 32 Global Osteoarthritis Injectables market: End-use outlook and key takeaways
  • Fig. 33 Hospital Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Retail Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Market share of key market players- Global Osteoarthritis Injectables market
  • Fig. 37 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 42 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 43 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 44 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 45 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 50 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 51 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 52 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 53 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 54 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 55 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 58 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 59 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 60 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 61 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 62 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 63 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 64 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)